Currently he coordinates all clinical trials with stem cells and gene therapy for cardiovascular diseases. His research focuses on acute myocardial infarction, ischemic heart disease, adult congenital heart disease, interventional cardiology and cardiac delivery technologies, having participated during the last 23 years in ten preclinical studies and in fifteen clinical trials in acute myocardial infarction, heart failure, refractory angina and regenerative products.